Conference abstract
Conference abstractPublished 15 Oct 2018
Finding pharmaceutical agents by assembling chemotypes
Sun Yat-sen University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This talk introduces a de novo chemotype (substructure) generation algorithm (DSGA) that derives frequent substructures in order to avoid the subjectivity of empirical method, and avoid the meaningless substructures generated from algorithmic approaches by statistical analyses. DSGA derives frequent chemical substructures (FCS) from a large compound library. In an FCS, substructures are not inter-included. When the library is big enough to represent the chemical diversity, such as ZINC database (27 million medicinal compounds), the resulting FCS is termed as the FCS dictionary (FCSD) for drug-like compounds. For a focused compound library (FL), DSGA can derive a focused FCS (fFCS) from FL. (fFCS) can be used as structural descriptors for focus library SAR studies. Six focused libraries against targets PDE4D, mTOR, HDAC1, DPP4, BACE and ALR2 were tested with DSGA approach. Using the (fFCS) as structural descriptor sets, six virtual screening models were generated to predict ligands against the targets; the prediction accuracies are greater than 90%. Three methods were proposed to assembly drug-like molecules from substructures: Using the laws in the nature, such as isoprene rule; organic synthesis rules, such as retro-synthon rules proposed by E J Corey; pharmaceutical rules derived from a focused compound library against a specific target. We use DSGA to figure out rules that are used to compose privileged scaffolds by assembling FCS. It can be chemically challenging to make the compounds proposed by these assembling approaches. By combining DSGA method, bioisosterism method and click chemistry, we generated privileged chemome (substructures/chemotypes) from Hsp90 inhibitor library, and then found out available chemical fragments with bioisosterism rules. With SPR technology, we confirmed the fragments that interacted with Hsp90. Finally, we used “click chemistry” to assemble the substructures and produced nanomolar selective Hsp90 inhibitors.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 13 Nov 2019
Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers
Conference abstract · 2017
Assembly of double-hydrophilic block copolymers triggered by gadolinium ions: New colloidal mri contrast agents
Conference abstract · 2017
Nitric oxide-releasing self-assembled nanoparticles as a chemo sensitizing agent for improved anticancer activity
Conference abstract · 6 Oct 2015
Self-assembling of bioactive agents âÂ?Â? A way to generate new drugs. The case of mesalamine: sucralfate complexes
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jun Xu”
- BylineArticles whose byline prints “Mengyang Xu”
- BylineArticles whose byline prints “Liangyue Wang”
- BylineArticles whose byline prints “Chao Zhao”
- BylineArticles whose byline prints “He Peng”
